Semaglutide Semaglutide is a GLP-1 receptor agonist that works by: Reducing appetite Slowing stomach emptying Supporting blood sugar regulation Increasing feelings of fullness It is commonly prescribed for: Chronic weight management Type 2 diabetes Metabolic health support Popular FDA-approved brands include: Ozempic Wegovy Rybelsus Tirzepatide Tirzepatide works on both: GLP-1 receptors GIP receptors This dual-action approach may help improve: Weight loss outcomes Blood sugar control Metabolic efficiency FDA-approved brands include: Mounjaro Zepbound Other FDA-Approved Peptide Therapies Additional peptide-based medications are used to treat conditions such as: Growth hormone deficiencies Fertility challenges Osteoporosis Hormonal disorders Diabetes management These therapies are prescribed and monitored by healthcare professionals to help ensure patient safety
Blend Composition PEPTIDE COMPONENTS BPC-157: 5mg (Body Protection Compound) GHK-Cu: 35mg (Copper Peptide) TB-500: 10mg (Thymosin Beta-4 Fragment) Ratio: 1:7:2 (BPC:GHK:TB) PHYSICAL PROPERTIES Total Weight: 50mg peptide blend Form: Lyophilized powder blend Color: Light blue tint (from GHK-Cu) Storage: Keep refrigerated 3646 F (28 C) Related products BPC-157 $40.00 $65.00Price range: $40.00 through $65.00 GHK-Cu $50.00 $90.00Price range: $50.00 through $90.00 CJC-1295 $60.00 $95.00Price range: $60.00 through $95.00 TB-500 $60.00 $90.00Price range: $60.00 through $90.00
The composition, preferably the water-soluble composition, of the invention may, in addition to the BPC peptide salt, further contain a water-soluble protein injectable into body fluids without showing any substantial pharmacological activity at the concentration used in one unit dosage form of the present invention (hereinafter, "water-soluble protein")
Within research settings, BPC-157 is studied as a signaling pathway modulator associated with cytoprotective responses, vascular regulation, and cellular processes involved in connective tissue biology
Like all medicines, it can cause side effects, but most are mild and manageable
